Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Private equity healthcare deals dropped 18.5% in Q2 2026, and states are stepping up. Eleven states have passed laws in the past two years targeting PE oversight — from ownership transparency to protecting physician autonomy. More bills are in the pipeline as officials try to keep pace with rapid healthcare market consolidation.
Private equity's footprint in healthcare is shrinking — at least for now. PE healthcare deals fell 18.5% in Q2 2026 compared to a year ago, with physician practice management and multispecialty provider deals on track to finish the year at roughly half their 2025 levels. Financial firm PitchBook points to a mix of economic headwinds and rising state-level regulatory scrutiny as key drivers of the slowdown.
High-profile collapses — most notably Steward Health Care's 2024 Chapter 11 bankruptcy with ~$9 billion in liabilities — have pushed state lawmakers to act. Eleven states (including California, Connecticut, Massachusetts, and Oregon) have enacted laws over the past two years requiring advance notice of deals, transaction reviews, and protections to keep clinical decision-making in physicians' hands. Some states are also restricting sale-leaseback arrangements, which a 2025 BMJ study linked to a 25% closure or bankruptcy rate among affected hospitals.
By the Numbers:
Why it matters: As healthcare consolidation accelerates, states are scrambling to understand who actually controls medical decisions — and what that means for patient access. Physicians are raising alarms about losing autonomy over hiring, billing, and service lines, while practices face mounting financial pressures that make outside investment hard to resist. The regulatory landscape is still evolving, and its full impact on PE activity remains to be seen.
